α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxy-3-fluorophenyl)methyl]phenyl]-

Shandong Boyuan Pharmaceutical Co., Ltd. was established in 2005. It is a high-tech enterprise specializing in R&D, production and sales of pharmaceutical intermediates and APIs.
After more than ten years of development, the company has formed a number of product systems with outstanding advantages, such as anti-tumor, anti-fungal, analgesic and anesthesia, and hypoglycemic.
The company has two factories in Jinan Jiyang base and Dezhou Yucheng base, covering an area of ​​more than 30,000 square meters; it has 12 GMP workshops, which can stably supply nearly 200 kinds of products, many of which have passed GMP, CEP, PDMA and other certification, and there are many varieties in the approval.
The company has always adhered to the innovation and development strategy, established a research and development team with more than 90 people, and has a number of invention patents with independent intellectual property rights. It has strong strength in synthesis technology and new variety development.
The company starts production from raw materials, and all intermediates and APIs can be sold. The products are abundant, the supply is timely, and the price advantage is significant.
The company is a manufacturer with a production license and GMP certification, with complete qualifications, which can meet the diverse needs of customers for information, testing, and auditing.
The company has become the raw material supplier of Hengrui, Yangzijiang, Simcere, Neptune and other large domestic pharmaceutical companies. At the same time, the products are exported to Europe, America, Japan, South Korea, India and other countries and regions, which are widely recognized by customers.
In the future, Boyuan Pharmaceutical will not forget its original intention, continue to innovate and develop, and achieve customers. Welcome new and old customers at home and abroad to discuss cooperation!